Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06665295 · ClinicalTrials.gov registry record · NA
THRIVE-CAR-T Digital App
A NA study, sponsored by Patrick C. Johnson, MD.
- Recruiting
- Registry status
- NA
- Development phase
- 100
- Enrollment target
NCT06665295: Recruiting NA study, sponsored by Patrick C. Johnson, MD.
NCT06665295 is a NA study that is actively recruiting participants, run by Patrick C. Johnson, MD. The registered enrollment target is 100 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06665295, a NA study, is actively recruiting participants, sponsored by Patrick C. Johnson, MD.
- RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to learn if a digital mobile application called THRIVE-CAR-T is helpful for the care of patients undergoing CAR-T cell therapy. The main question\[s\] it aims to answer are whether the THRIVE-CAR-T app is feasible and acceptable to patients.
Primary Outcome
Feasibility is defined based on the rate of patient enrollment. THRIVE-CAR-T will be deemed feasible if rates of enrollment are \>= 60%, and among those enrolled and randomized to THRIVE-CAR-T, 60% complete 3 out of 5 modules. For patients who either die prior to the end of the intervention or are admitted to the intensive care unit (ICU), the latter definition of feasibility will be completion of 60% of expected modules at the time of clinical deterioration.
Interventions
- BEHAVIORAL THRIVE-CAR-T
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2024-10-17 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
What NCT06665295 shows while recruiting
NCT06665295 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 1 intervention - of which THRIVE-CAR-T is the first listed.
NCT06665295 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06665295 about?
NCT06665295 is a clinical study titled "THRIVE-CAR-T Digital App". The goal of this clinical trial is to learn if a digital mobile application called THRIVE-CAR-T is helpful for the care of patients undergoing CAR-T cell therapy. The main question\[s\] it aims to answer are whether the THRIVE-CAR-T app is feasible and acceptable to patients.
What is the current status of trial NCT06665295?
This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2024-10-17. Estimated completion is 2026-12-31.
What interventions are being tested in trial NCT06665295?
The interventions under investigation include: THRIVE-CAR-T (BEHAVIORAL).
Who is sponsoring clinical trial NCT06665295?
This trial is sponsored by Patrick C. Johnson, MD, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06665295's enrollment target sits among peer trials
100 840th of 2000 higher than 1,081 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI